Bacterial cell envelope and cytoplasmic membrane phospholipids and anionic cell wall components

The bacterial cell envelope and cytoplasmic membrane phospholipids, along with anionic cell wall components, constitute the essential structural and protective barrier of the bacterial cell (Silhavy et al., 2010). This complex target includes the inner cytoplasmic membrane, characterized by high concentrations of anionic phospholipids like phosphatidylglycerol and cardiolipin, and the cell wall, which contains anionic polymers such as teichoic acids in Gram-positive bacteria or lipopolysaccharides in the outer membrane of Gram-negative bacteria (Sieradzki et al., 1999). These components are vital for maintaining cellular homeostasis, osmotic stability, and providing a scaffold for membrane-bound enzymes. Because eukaryotic membranes are primarily composed of zwitterionic lipids and cholesterol, the highly negative charge of the bacterial surface allows for selective targeting by cationic antimicrobial peptides and lipopeptides (Brogden, 2005). Therapeutic agents like daptomycin and polymyxins bind to these anionic sites, leading to membrane permeabilization, loss of membrane potential, and rapid cell death (Straus & Hancock, 2006). This target group is critical in the fight against multi-drug resistant pathogens, though resistance can emerge through modifications of the cell surface charge.

Other names

Bacterial cell envelopeBacterial membrane lipidsAnionic cell wall polymersBacterial surface components

Antibiotics targeting these components generally utilize electrostatic interactions to bind anionic lipids or cell wall polymers, leading to membrane depolarization, physical disruption (pore formation), or the sequestration of lipid-linked precursors necessary for peptidoglycan synthesis (Brogden, 2005; Straus & Hancock, 2006).